Annual Cash & Cash Equivalents
$37.71 M
-$70.59 M-65.18%
31 December 2023
Summary:
PMV Pharmaceuticals annual cash & cash equivalents is currently $37.71 million, with the most recent change of -$70.59 million (-65.18%) on 31 December 2023. During the last 3 years, it has fallen by -$323.72 million (-89.57%). PMVP annual cash & cash equivalents is now -89.57% below its all-time high of $361.42 million, reached on 31 December 2020.PMVP Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$48.81 M
+$284.00 K+0.59%
30 September 2024
Summary:
PMV Pharmaceuticals quarterly cash and cash equivalents is currently $48.81 million, with the most recent change of +$284.00 thousand (+0.59%) on 30 September 2024. Over the past year, it has dropped by -$3.25 million (-6.24%). PMVP quarterly cash and cash equivalents is now -86.92% below its all-time high of $373.15 million, reached on 30 September 2020.PMVP Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PMVP Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -65.2% | -6.2% |
| 3 y3 years | -89.6% | -72.4% |
| 5 y5 years | +24.4% | - |
PMVP Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -89.6% | at low | -72.4% | +29.4% |
| 5 y | 5 years | -89.6% | +24.4% | -86.9% | +29.4% |
| alltime | all time | -89.6% | +24.4% | -86.9% | +29.4% |
PMV Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $48.81 M(+0.6%) |
| June 2024 | - | $48.53 M(+1.8%) |
| Mar 2024 | - | $47.65 M(+26.4%) |
| Dec 2023 | $37.71 M(-65.2%) | $37.71 M(-27.6%) |
| Sept 2023 | - | $52.06 M(-23.7%) |
| June 2023 | - | $68.21 M(-52.3%) |
| Mar 2023 | - | $142.94 M(+32.0%) |
| Dec 2022 | $108.30 M | $108.30 M(+8.5%) |
| Sept 2022 | - | $99.85 M(+14.7%) |
| June 2022 | - | $87.09 M(-24.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $115.77 M(-32.9%) |
| Dec 2021 | $172.47 M(-52.3%) | $172.47 M(-2.4%) |
| Sept 2021 | - | $176.64 M(-6.7%) |
| June 2021 | - | $189.42 M(-9.3%) |
| Mar 2021 | - | $208.78 M(-42.2%) |
| Dec 2020 | $361.42 M(+393.2%) | $361.42 M(-3.1%) |
| Sept 2020 | - | $373.15 M(+152.1%) |
| June 2020 | - | $148.02 M(+102.0%) |
| Dec 2019 | $73.28 M(+141.8%) | $73.28 M |
| Dec 2018 | $30.31 M | - |
FAQ
- What is PMV Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for PMV Pharmaceuticals?
- What is PMV Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is PMV Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for PMV Pharmaceuticals?
- What is PMV Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is PMV Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of PMVP is $37.71 M
What is the all time high annual cash & cash equivalents for PMV Pharmaceuticals?
PMV Pharmaceuticals all-time high annual cash & cash equivalents is $361.42 M
What is PMV Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, PMVP annual cash & cash equivalents has changed by -$70.59 M (-65.18%)
What is PMV Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of PMVP is $48.81 M
What is the all time high quarterly cash and cash equivalents for PMV Pharmaceuticals?
PMV Pharmaceuticals all-time high quarterly cash and cash equivalents is $373.15 M
What is PMV Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, PMVP quarterly cash and cash equivalents has changed by -$3.25 M (-6.24%)